Jun 18, 2026 08:00AM
Jun 8, 2026 08:00AM
Jun 8, 2026 08:00AM
May 27, 2026 08:00AM
May 12, 2026 07:35AM
May 12, 2026 07:30AM
May 12, 2026 07:30AM Coya Therapeutics Has Been Granted U.S. FDA Fast Track Designation for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Apr 9, 2026 08:01AM
Apr 9, 2026 08:00AM
Apr 2, 2026 08:01AM
Apr 2, 2026 08:00AM
Mar 24, 2026 08:01AM
Mar 24, 2026 08:00AM
Mar 18, 2026 08:00AM Coya Therapeutics study shows immune dysfunction in dementia patients
Mar 18, 2026 08:00AM
Mar 16, 2026 08:00AM
Feb 10, 2026 08:00AM
Jan 30, 2026 08:00AM
Jan 30, 2026 08:00AM
Jan 20, 2026 08:04AM
Jan 20, 2026 08:00AM Coya Therapeutics CEO Dr. Arun Swaminathan Issues Letter to Stockholders
Jan 8, 2026 08:02AM
Jan 8, 2026 08:00AM
Jan 5, 2026 08:03AM
Jan 5, 2026 08:00AM
Dec 23, 2025 08:01AM
Dec 23, 2025 08:00AM
Dec 9, 2025 08:00AM Coya Therapeutics Announces Patients Have Been Dosed in the ALSTARS Trial of COYA 302 for the Treatment of ALS
Nov 25, 2025 08:00AM
Nov 12, 2025 08:00AM
Oct 27, 2025 04:01PM
Oct 27, 2025 04:01PM
Oct 24, 2025 06:30AM
Oct 24, 2025 06:30AM
Oct 23, 2025 04:31PM Coya Therapeutics announces proposed public stock offering
Oct 23, 2025 04:31PM
Sep 22, 2025 08:01AM
Sep 22, 2025 08:00AM
Sep 4, 2025 08:03AM
Sep 4, 2025 08:00AM
Sep 3, 2025 11:50AM
Aug 25, 2025 08:00AM Coya Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Aug 25, 2025 06:42AM
Aug 25, 2025 05:22AM
Aug 12, 2025 08:00AM
Jul 24, 2025 08:15AM
Jul 24, 2025 08:15AM
Jul 22, 2025 08:15AM
Jun 18, 2025 08:15AM Coya Therapeutics to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24 – 25, 2025
Jun 2, 2025 08:02AM

323,580 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All